A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro™) in patients with type 2 diabetes

Food and Nutrition Research

Volumn 60, Issue 1, 2016, Pages

  Verma, Narsingh ^a   Usman, Kauser ^a   Patel, Naresh ^a   Jain, Arvind ^a   Dhakre, Sudhir ^a   Swaroop, Anand ^b   Bagchi, Manashi ^b   Kumar, Pawan ^c   Preuss, Harry G ^d   Bagchi, Debasis ^b,e  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Cepham Inc   (United States)

^c Research and Development Arobot   (India)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF HOUSTON   (United States)

Author keywords

Blood pressure; Blood sugar; C peptide; Fenugreek seed extract (Fenfuro); HbA1c; Safety; Type 2 diabetes (T2D)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C PEPTIDE; CREATININE; FENUGREEK EXTRACT; GLUCOSE; HEMOGLOBIN A1C; NITROGEN; PLACEBO; UREA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CHEMISTRY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL;

EID: 85017394631     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.3402/fnr.v60.32382     Document Type: Article

References (43)

1. Bagchi D, Sreejayan N, eds., Nutritional and therapeutic interventions for diabetes and metabolic syndrome. Amsterdam: Academic Press; 2012.
2. Diseases and conditions. Type 2 diabetes. Available from: http://www.mayoclinic.org/diseases-conditions/type-2-diabetes/basics/complications/con-20031902 [cited 22 August 2015].
3. National diabetes statistics. Available from: http://diabetes.niddk.nih.gov/dm/pubs/statistics/2011 [cited 20 August 2015].
4. Diabetes: facts and figures. International Diabetes Federation. Available from: http://www.idf.org/worlddiabetesday/toolkit/gp/facts-figures [cited 22 August 2015].
5. Taylor SR, Meadowcraft LM, Willamson B. Prevalence, pathophysiology, and management of androgen deficiency in men with metabolic syndrome, type 2 diabetes mellitus, or both. Pharmacotherapy 2015; 35(8): 780-92.
6. Park KS. The search for genetic risk factors of type 2 diabetes mellitus. Diabetes Metab J 2011; 35: 12-22.
7. Cooper ME, El-Osta A. Epigenetics: mechanisms and implications for diabetic complications. Circ Res 2010; 107: 1403-13.
8. Marfella R, Paolisso G. Antidiabetic drugs for elderly population. In: Bagchi D, Nair S, eds. Nutritional and therapeutic interventions for diabetes and metabolic syndrome. Amsterdam: Academic Press; 2012, pp. 475-97.
9. Leiri I. Pharmacokinetics and pharmacodynamics of antidiabetic drugs-from the viewpoints of drug transporters and metabolic enzymes. Nihon Rinsho 2015; 73(3): 358-62.
10. Zhou X, Xu J, Shi Y, Ye JM. Discovery of novel anti-diabetic drugs by targeting lipid metabolism. Curr Drug Targets 2015; 16(12): 1372-80.
11. Yanai H, Adachi H, Katsuyama H, Moriyama S, Hamasaki H, Sako A. Causative anti-diabetic drugs and the underlying clinical factors for hypoglycemia in patients with diabetes. World J Diabetes 2015; 6(1): 30-6.
12. Smith JD, Clinard VB. Natural products for the management of type 2 diabetes mellitus and comorbid conditions. J Am Pharm Assoc 2014; 54(5): 304-18.
13. Dragan S, Andrica F, Serban MC, Timar R. Polyphenols-rich natural products for treatment of diabetes. Curr Med Chem 2015; 22(1): 14-22.
14. Zatalia SR, Sanusi H. The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta Med Indones 2013; 45(2): 141-7.
15. Lee T, Dugoua JJ. Nutritional supplements and their effects on glucose control. Adv Exp Med Biol 2012; 771: 381-95.
16. Bahmani M, Shirzad H, Mirhosseini M, Mesripour A, Rafieian-Kopaei M. A review on ethnobotanical and therapeutic uses of fenugreek (Trigonella foenum-graceum L). J Evid Based Complementary Altern Med 2016; 21(1): 53-62.
17. Natural medicines comprehensive database. Available from: http://naturaldatabase.therapeuticresearch.com/home.aspx?cs=&s=ND&AspxAutoDetectCookieSupport=1 [cited 20 August 2015].
18. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007; 40: 163-73.
19. Ballali S, Lanciai F. Functional food and diabetes: a natural way in diabetes prevention? Int J Food Sci Nutr 2012; 63(SUPPL. 1): 51-61.
20. Basch E, Ulbricht C, Kuo G, Szapary P, Smith M. Therapeutic applications of fenugreek. Altern Med Rev 2003; 8(1): 20-7.
21. Baquer NZ, Kumar P, Taha A, Kale RK, Cowsik SM, McLean P. Metabolic and molecular action of Trigonella foenum-graecum (fenugreek) and trace metals in experimental diabetic tissues. J Biosci 2011; 36(2): 383-96.
22. Ulbricht C, Basch E, Burke D, Cheung L, Ernst E, Giese N, et al. Fenugreek (Trigonella foenum-graecum Leguminosae): an evidence-based systematic review by the natural standard research collaboration. J Herb Pharmacother 2007; 7(3-4): 143-77.
23. Yadav UC, Baquer NZ. Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm Biol 2014; 52(2): 243-54.
24. Haber SL, Keonavong J. Fenugreek use in patients with diabetes mellitus. Am J Health Syst Pharm 2013; 70(14): 1196, 1198, 1200, 1202-3. doi: http://dx.doi.org/10.2146/ajhp120523
25. Roberts KT. The potential of fenugreek (Trigonella foenumgraecum) as a functional food and nutraceutical and its effects on glycemia and lipidemia. J Med Food 2011; 14(12): 1485-9.
26. Fuller S, Stephens JM. Diosgenin, 4-hydroxyisoleucine, and fiber from fenugreek: mechanisms of actions and potential effects on metabolic syndrome. Adv Nutr 2015; 6(2): 189-97.
27. Pribaci GC, Sferdian MF, Neamtu C, Craciun C. Fenugreek powder exerts protective effects on alcoholised rats' kidney, highlighted using ultrastructural studies. Rom J Morphol Embryol 2015; 56(2): 445-51.
28. Swaroop A, Bagchi M, Kumar P, Preuss HG, Tiwari K, Marone PA, et al. Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella foenumgraecum seed extract (Fenfuro). Toxicol Mech Methods 2014; 24(7): 495-503.
29. TM) inhibits diet-induced insulin resistance and hepatic fat accumulation. Mol Nutr Food Res 2015; 59(10): 2094-100.
30. Extract obtained by a commercially viable process for the extraction of furostanolic saponins from fenugreek seeds, in which one of the compounds in the extract is protodioscin. Inventor: PK. Goel. United States Patent 8,754,205B2, Date of Patent, 17 June 2014.
31. Process for the extraction of furostanolic saponins from fenugreek seeds. Inventor: PK. Goel. United States Patent US008217165B2, Date of Patent, 10 July 2012.
32. Hibasami H, Moteki H, Ishikawa K, Katsuzaki H, Imai K, Yoshioka K, et al. Protodioscin isolated from fenugreek (Trigonella foenum-graceum L.) induces cell death and morphological change indicative of apoptosis in leukemic cell line HL-60, but not in gastric cancer cell line Kato III. Int J Mol Med 2003; 11(1): 23-6.
33. Elujoba AA, Hardman R. Saponin-hydrolyzing enzymes from fenugreek seed. Fitoterapia 1987; 58: 197-9.
34. Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenum-graceum Linn.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997; 56: 379-84.
35. Valette G, Sauvaire Y, Baccou JC, Ribes G. Hypocholesterolaemic effect of fenugreek seeds in dogs. Atherosclerosis 1984; 50: 105-11.
36. Gupta RK, Jain DC, Thakur RS. Minor steroidal sapogenins from fenugreek seeds, Trigonella foenum-graecum. J Nat Prod 1986; 49: 1153-6.
37. Madar Z, Abel R, Samish S, Arad J. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics. Eur J Clin Nutr 1988; 42: 51-4.
38. Sauvaire Y, Baccou JC. Extraction of diosgenin, (25R)-spirost-5-ene-3-beta-ol; problems of the hydrolysis of the saponins. Lloydia 1978; 41: 247-56.
39. Sauvaire Y, Ribes G, Baccou JC, Loubatieeres-Mariani MM. Implication of steroid saponins and sapogenins in the hypocho-lesterolemic effect of fenugreek. Lipids 1991; 26: 191-7.
40. Prasanna M. Hypolipidemic effect of fenugreek: a clinical study. Indian J Pharmacol 2000; 32: 34-6.
41. Neelakantan N, Narayanan M, de Souza RJ, van Dam RM. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials. Nutr J 2014; 13: 1-11.
42. Neha S, Anand K, Sunanda P. Administration of fenugreek seed extract produces better effects in the glibenclamide-induced inhibition of hepatic lipid peroxidation: an in vitro study. Chin J Integr Med 2015. doi: http://dx.doi.org/10.1007/s11655-015-1793-Z
43. Sharma RD, Raghuram TC, Rao NS. Effect of fenugreek seeds on blood glucose and serum lipids in type 1 diabetes. Eur J Clin Nutr 1990; 44: 301-6.